SGA
RIGL icon

Sector Gamma AS’s Rigel Pharmaceuticals RIGL Stock Holding History

Sector Gamma AS’s Portfolio RIGL Stock Details RIGL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-134,690
Closed -$1.59M – 35
2022
Q3 		$1.59M Sell
134,690
-11,978
-8% -$162K 0.41% 28
2022
Q2 		$1.66M Hold
146,668
– – 0.37% 33
2022
Q1 		$4.38M Sell
146,668
-292
-0.2% -$7.91K 0.95% 29
2021
Q4 		$3.89M Sell
146,960
-30,313
-17% -$915K 0.92% 28
2021
Q3 		$6.43M Buy
177,273
+6,718
+4% +$264K 1.28% 25
2021
Q2 		$7.4M Buy
170,555
+17,506
+11% +$661K 1.31% 28
2021
Q1 		$5.23M Sell
153,049
-6,816
-4% -$270K 0.96% 29
2020
Q4 		$5.59M Buy
159,865
+23,336
+17% +$676K 1.06% 26
2020
Q3 		$3.28M Buy
+136,529
New +$3.35M 0.75% 25

Other funds holding RIGL

AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Jacobs Levy Equity Management
Jacobs Levy Equity Management Florham Park, New Jersey $23.8B AUM 25.4% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Sector Gamma AS's RIGL Position: Q4 2022 in Review

Sector Gamma AS sold out of Rigel Pharmaceuticals (RIGL) in Q4 2022, closing a stake of 134,690 shares — an estimated $1.59M sold.

Sector Gamma AS first reported a position in RIGL in Q3 2020 and held it in 9 quarters. The position peaked at $7.4M in Q2 2021. 118 funds tracked by Wall St. Rank hold RIGL as of Q4 2022.

  • Sector Gamma AS reported no remaining Rigel Pharmaceuticals position as of Q4 2022 after selling out during the quarter.
  • Sector Gamma AS sold 134,690 Rigel Pharmaceuticals shares in Q4 2022, an estimated $1.59M.
  • Sector Gamma AS first reported a position in Rigel Pharmaceuticals in Q3 2020 and held it in 9 quarters.
  • Sector Gamma AS's Rigel Pharmaceuticals position peaked at $7.4M in Q2 2021.
  • 118 funds tracked by Wall St. Rank held Rigel Pharmaceuticals as of Q4 2022.

Based on Sector Gamma AS's 13F filing for Q4 2022, filed 7 Feb 2023.